Skip to main content
. 2008 Apr 16;2008(2):CD005589. doi: 10.1002/14651858.CD005589.pub2
Survival
Study Topotecan group PLD group p value
Median survival (by week)
Gordon 2004a 59.7 62.7  
median survival‐platium‐sensitive(by week)
Gordon 2004a 70.1 107.9  
median survival‐platium‐resistant(by week)
Gordon 2004a 41.3 35.6 0.455